Related references
Note: Only part of the references are listed.Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS
A. Yamazaki et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Interindividual variability in acetaminophen sulfation by human fetal liver: Implications for pharmacogenetic investigations of drug-induced birth defects
Araba A. Adjei et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2008)
Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics
Graham Lappin et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Microdose clinical trial: Quantitative determination of fexofenadine in human plasma using liquid chromatography/electro spray ionization tandem mass spectrometry
Naoe Yamane et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices
Yoshitane Nozaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs
Graham Lappin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Intracellular signaling mechanisms of acetaminophen-induced liver cell death
H Jaeschke et al.
TOXICOLOGICAL SCIENCES (2006)
A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters
H Tahara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Role of metabolism in drug-induced idiosyncratic hepatotoxicity
JL Walgren et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Acetaminophen-induced hepatotoxicity
LP James et al.
DRUG METABOLISM AND DISPOSITION (2003)
Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor
RC Garner et al.
DRUG METABOLISM AND DISPOSITION (2002)
A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts
RC Garner et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)
Share Paper
